Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 6, 2000, Pages 2048-2052

  Grembiale, Rosa D ^b   Camporota, Luigi ^a   Naty, Saverio ^b   Tranfa, Carmelindo M E ^b   Djukanovic, Ratko ^b   Marsico, Serafino A ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CONJUVAC; IMMUNOGLOBULIN E; METHACHOLINE; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MALE; PERENNIAL RHINITIS; PRIORITY JOURNAL; PROPHYLAXIS; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RISK; SCHOOL CHILD;

EID: 0034524222     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.6.9909087     Document Type: Article

References (36)

1. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function: The Normative Aging Study
2. The presence of airway reactivity before the development of asthma
3. Skin test reactivity to common aeroallergens and decline of lung function: The Normative Aging Study
4. Prognosis of asthma from childhood to adulthood
5. Asymptomatic bronchial hyperresponsiveness in rhinitis
6. Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students
7. The natural course of allergic rhinitis during 12 years of follow-up
8. Epidemiology of physician-diagnosed allergic rhinitis in childhood
9. Asymptomatic airway hyperresponsiveness: A three-year follow-up
10. Position paper: Immunotherapy
11. Is immunotherapy for asthma worthwhile?
12. Airway remodeling and repair
13. Immunotherapy with partially purified and standardized tree pollen extracts: IV. Results from long-term (6-year) follow-up
14. Capacity of specific immunotherapy in prevention of allergic asthma in children: The Preventive Allergy Treatment Study (PAT)
15. Intrasubject between-day variability of PD20 methacholine assessed by the dosimeter inhalation test
16. Airway responsiveness: Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report of the Working Party on Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society
17. Measuring changes in logarithmic data, with special reference to bronchial responsiveness
18. A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis: 1. Clinical aspects
19. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials
20. Allergen immunotherapy: Therapeutic vaccines for allergic diseases
21. Birth season variation in asthma and allergic rhinitis
22. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: The Normative Aging Study
23. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function: The Normative Aging Study
24. Is asymptomatic bronchial hyperresponsiveness an indication of potential asthma? A two-year follow-up of young students with bronchial hyperresponsiveness
25. Asymptomatic bronchial hyperreactivity and the development of asthma and other respiratory tract illnesses in children
26. Airway responsiveness and atopy in families of patients with asthma
27. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls
28. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma
29. 1 in adult men: An epidemiologic longitudinal study
30. Immunotherapy and allergic inflammation
31. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy
32. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
33. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals
34. Bee venom immunotherapy results in decrease of IL-4 and 1L-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures
35. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes